Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407469 · ClinicalTrials.gov registry record
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
A clinical trial of Cancer-related Venous Thromboembolism, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 260
- Enrollment target
- 4
- Study locations
NCT03407469: Recruiting study of Cancer-related Venous Thromboembolism, sponsored by M.D. Anderson Cancer Center.
NCT03407469 is a study of Cancer-related Venous Thromboembolism that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 260 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03407469, a study of Cancer-related Venous Thromboembolism, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.
Primary Outcome
Adherence categorized as "adequate" versus "non-adequate" based on the Morisky scale.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (4)
Other
- Fundacion Valle del Lili - Cali
- Hospital German Trias i Pujol - Barcelona
Texas
- University of Texas MD Anderson Cancer Center - Houston
Carrer de Villarroel, 170
- Hospital Clinic - Barcelona
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2018-01-12 |
| Est. Completion | 2026-12-31 |
What NCT03407469 shows while recruiting
NCT03407469 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cancer-related Venous Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT03407469 reports a single indexed study location in Other, Texas, Carrer de Villarroel, 170.
Frequently Asked Questions
What is clinical trial NCT03407469 about?
NCT03407469 is a clinical study titled "Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization". The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enro...
What is the current status of trial NCT03407469?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2018-01-12. Estimated completion is 2026-12-31.
What conditions does trial NCT03407469 study?
This clinical trial studies the following conditions: Cancer-related Venous Thromboembolism.
What interventions are being tested in trial NCT03407469?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03407469?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03407469 being conducted?
This trial has 4 study locations across Texas, Carrer de Villarroel, 170. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
- NCT04230109 · 260 participants · Phase 2
Sacituzumab Govitecan In TNBC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI